Fayong Luo

1.7k total citations
15 papers, 1.1k citations indexed

About

Fayong Luo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Fayong Luo has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Fayong Luo's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Neonatal Respiratory Health Research (4 papers). Fayong Luo is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Neonatal Respiratory Health Research (4 papers). Fayong Luo collaborates with scholars based in United States, United Kingdom and Sweden. Fayong Luo's co-authors include Cecilia G. Sánchez, Michael R. Blackburn, Rafael Góngora, Chunmin Dong, Jose G. Molina, Harry Karmouty‐Quintana, Svitlana Danchuk, Jonathan Davies, Kemly Philip and Tingting Weng and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Fayong Luo

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fayong Luo United States 14 552 337 156 136 114 15 1.1k
Jeffrey D. Ritzenthaler United States 16 449 0.8× 467 1.4× 145 0.9× 133 1.0× 108 0.9× 35 1.2k
Andreas Schwingshackl United States 17 388 0.7× 285 0.8× 154 1.0× 110 0.8× 186 1.6× 51 951
Tommaso Neri Italy 19 316 0.6× 545 1.6× 158 1.0× 82 0.6× 61 0.5× 58 935
Tatiana Victoni France 14 178 0.3× 229 0.7× 219 1.4× 107 0.8× 82 0.7× 22 711
Anantha Harijith United States 20 449 0.8× 718 2.1× 241 1.5× 116 0.9× 163 1.4× 36 1.3k
Cemil Korcan Ayata Germany 18 153 0.3× 348 1.0× 270 1.7× 89 0.7× 148 1.3× 24 971
Huanying Wan China 16 255 0.5× 203 0.6× 172 1.1× 47 0.3× 225 2.0× 34 909
Manfred W. Ziegenhagen Germany 15 716 1.3× 201 0.6× 137 0.9× 140 1.0× 631 5.5× 23 1.1k
Jiong Yang China 20 243 0.4× 207 0.6× 483 3.1× 114 0.8× 498 4.4× 61 1.2k
Johan Sällström Sweden 22 106 0.2× 431 1.3× 115 0.7× 148 1.1× 169 1.5× 52 1.2k

Countries citing papers authored by Fayong Luo

Since Specialization
Citations

This map shows the geographic impact of Fayong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fayong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fayong Luo more than expected).

Fields of papers citing papers by Fayong Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fayong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fayong Luo. The network helps show where Fayong Luo may publish in the future.

Co-authorship network of co-authors of Fayong Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Fayong Luo. A scholar is included among the top collaborators of Fayong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fayong Luo. Fayong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Saito, Shigeki, Yan Zhuang, Bin Shan, et al.. (2017). Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. PLoS ONE. 12(10). e0186615–e0186615. 91 indexed citations
2.
Guo, Weichao, Shigeki Saito, Cecilia G. Sánchez, et al.. (2017). TGF-β1 stimulates HDAC4 nucleus-to-cytoplasm translocation and NADPH oxidase 4-derived reactive oxygen species in normal human lung fibroblasts. American Journal of Physiology-Lung Cellular and Molecular Physiology. 312(6). L936–L944. 27 indexed citations
3.
Philip, Kemly, Jonathan Davies, Ning‐Yuan Chen, et al.. (2017). HIF1A up‐regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis. The FASEB Journal. 31(11). 4745–4758. 59 indexed citations
4.
Dong, Chunmin, et al.. (2016). Regulation of transforming growth factor-beta1 (TGF-β1)-induced pro-fibrotic activities by circadian clock gene BMAL1. Respiratory Research. 17(1). 4–4. 77 indexed citations
5.
He, Baokun, Thomas K. Hoang, Ting Wang, et al.. (2016). Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency–induced autoimmunity via adenosine A2A receptors. The Journal of Experimental Medicine. 214(1). 107–123. 146 indexed citations
6.
Chen, Ning-Yuan, Scott D. Collum, Fayong Luo, et al.. (2016). Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 311(2). L238–L254. 66 indexed citations
7.
Garcia‐Morales, Luis J., Ning-Yuan Chen, Tingting Weng, et al.. (2015). Altered Hypoxic–Adenosine Axis and Metabolism in Group III Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 54(4). 574–583. 34 indexed citations
8.
Góngora, Rafael, et al.. (2015). Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1. Aging Cell. 14(5). 774–783. 136 indexed citations
9.
Luo, Fayong, Tingting Mills, Ning‐Yuan Chen, et al.. (2015). Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis. The FASEB Journal. 30(2). 874–883. 39 indexed citations
10.
Weng, Tingting, Jens M. Poth, Harry Karmouty‐Quintana, et al.. (2014). Hypoxia-induced Deoxycytidine Kinase Contributes to Epithelial Proliferation in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 190(12). 1402–1412. 44 indexed citations
12.
Karmouty‐Quintana, Harry, Ernestina Melicoff, Tingting Weng, et al.. (2014). Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis. The Journal of Immunology. 193(7). 3755–3768. 235 indexed citations
13.
Karmouty‐Quintana, Harry, Kemly Philip, Luis Acero, et al.. (2014). Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension. The FASEB Journal. 29(1). 50–60. 59 indexed citations
14.
Davies, Jonathan, Harry Karmouty‐Quintana, Ning‐Yuan Chen, et al.. (2014). Adenosine promotes vascular barrier function in hyperoxic lung injury. Physiological Reports. 2(9). e12155–e12155. 25 indexed citations
15.
Luo, Fayong, et al.. (2013). Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma. Virology Journal. 10(1). 152–152. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026